摘要
目的 探究适用于精神病福利院精神分裂症合并糖尿病患者的综合健康管理策略及应用价值。方法 本研究选取精神病福利院2025年1-12月收治的精神分裂症合并糖尿病患者100例为研究对象,实施为期6个月的综合健康管理,涵盖多学科协作诊疗、用药优化、饮食运动干预、心理社会支持及并发症防控等措施。比较管理前后患者精神症状评分、血糖指标、治疗依从性及并发症发生率。结果 管理后患者PANSS评分、空腹血糖、餐后2h血糖及糖化血红蛋白水平均显著降低,治疗依从率提升,并发症总发生率降低,差异均有统计学意义(P<0.05)。结论 针对性综合健康管理可有效改善此类患者精神症状与血糖控制效果,提升治疗依从性,降低并发症风险,适配福利院照护场景,具有较高临床应用价值。
关键词: 精神病福利院;精神分裂症;糖尿病;共病;综合健康管理
Abstract
Objective To explore the comprehensive health management strategies and their application value for patients with schizophrenia and diabetes in psychiatric welfare institutions. Methods A total of 100 patients with schizophrenia and diabetes admitted to a psychiatric welfare institution from January to December 2025 were selected as the study subjects. A 6-month comprehensive health management program was implemented, covering multidisciplinary collaborative diagnosis and treatment, medication optimization, dietary and exercise interventions, psychosocial support, and complication prevention. The psychiatric symptom scores, blood glucose indicators, treatment adherence, and complication incidence were compared before and after management. Results After management, the PANSS scores, fasting blood glucose, 2-hour postprandial blood glucose, and glycated hemoglobin levels of the patients were significantly reduced. The treatment adherence rate increased, and the overall complication incidence decreased, with all differences being statistically significant (P<0.05). Conclusion Targeted comprehensive health management can effectively improve the psychiatric symptoms and blood glucose control in such patients, enhance treatment adherence, reduce the risk of complications, and is suitable for the care setting of welfare institutions, demonstrating high clinical application value.
Key words: Psychiatric welfare institution; Schizophrenia; Diabetes; Comorbidity; Comprehensive health management
参考文献 References
[1] 赖元桂,苏海燕,任小琼. 基于循证支持的Orem自理模式干预对糖尿病合并精神分裂症患者疾病管理能力及疾病认知的影响[J]. 糖尿病新世界,2025,28(10):145-148.
[2] 陈敏敏,黄奕强,杨国平,等. 2型糖尿病与精神分裂症共病患者的自我管理障碍与促成因素分析[J]. 糖尿病新世界,2021,24(2):11-15,27.
[3] 冯银解,岑结容,李金浓,等. 精神分裂症合并2型糖尿病患者自我管理现状的调查[J]. 中国医药科学,2020,10(6): 215-217,258.
[4] 张伟波,李江楠,刘彦丽,等. 上海市社区精神分裂症患者共病慢性躯体疾病的状况及影响因素分析[J]. 复旦学报(医学版),2025,52(4):484-491,499.
[5] 陈灿,刘羽茜,王婷,等. 基于计划行为理论的干预策略对男性精神分裂症合并糖尿病患者血糖自我管理能力的影响[J]. 江苏卫生事业管理,2023,34(12):1751-1754, 1763.
[6] 蒋菊芳,裴建琴,张紫娟,等. 延续性自我管理教育对精神分裂症合并糖尿病患者服药依从性与自我效能的效果观察[J]. 中国实用护理杂志,2017,33(15):1155-1159.
[7] 胡耀华,林明钦,邹敏,等. 叙事疗法结合PDCA循环管理在精神分裂症伴糖尿病患者中的应用[J]. 中外医学研究,2020,18(17):168-170.
[8] 陈敏敏,黄奕强,彭桂华,等. 惠州市精神分裂症人群中2型糖尿病患者健康管理效果分析[J]. 疾病预防控制通报,2022,37(1):13-17.
[9] 范誉,钟少玲,周亮,等. 社区精神分裂症患者代谢综合征影响因素[J]. 四川精神卫生,2023,36(6):515-520,531.
[10] 罗兴能,周文洁,黄浩然,等. 重庆市沙坪坝区精神分裂症合并糖尿病患者疾病特征分析[J]. 现代医药卫生,2020, 36(2):177-179.
[11] 裴可灵,吴钰倩,李尧,等. 阿立哌唑治疗女性精神分裂症的研究现状[J]. 中国临床药理学杂志,2022,38(15): 1827 -1830,1840.
[12] 段建丽. 精神分裂症患者的糖脂代谢与健康饮食[J]. 人人健康,2025(13):22-23.
[13] 袁蓓,宋世蓓,唐潇,等. 慢性精神分裂症共患病调查[J]. 河南医学高等专科学校学报,2023,35(6):634-637.